XPO1 and cancer: Significantly for cancer treatment, XPO1 inhibition can promote a positive immune response against cancer via macrophage re-polarisation to the M1-like phenotype, modulation of T cell checkpoints, sensitisation of cancer cells to NK cell and T cell lysis, and inhibition of neutrophil extracellular traps.